Jonathan Robbins, chair of Akerman’s Cannabis Practice, will serve as a panelist for the webinar, “Schedule III Classification of Cannabis: Banking, Capital, and Tax Planning for Medical Cannabis Businesses,” presented by BARBRI. The program will examine the legal, financial, and operational implications of the federal government’s recent actions regarding the Schedule III classification of cannabis for medical purposes.

The discussion will explore how the evolving regulatory framework may affect banking relationships, access to capital, tax planning opportunities, and compliance obligations for medical cannabis businesses and the financial institutions that serve them. Panelists will also address the impact of Internal Revenue Code Section 280E, emerging business opportunities, and key considerations arising from ongoing federal rulemaking and related developments.